High-Affinity Anti-Ganglioside IgG Antibodies Raised in Complex Ganglioside Knockout Mice

2001 ◽  
Vol 75 (1) ◽  
pp. 404-412 ◽  
Author(s):  
Michael P. T. Lunn ◽  
L'Aurelle A. Johnson ◽  
Susan E. Fromholt ◽  
Saki Itonori ◽  
Jian Huang ◽  
...  
2015 ◽  
Vol 58 (15) ◽  
pp. 6195-6213 ◽  
Author(s):  
Comfort A. Boateng ◽  
Oluyomi M. Bakare ◽  
Jia Zhan ◽  
Ashwini K. Banala ◽  
Caitlin Burzynski ◽  
...  

2013 ◽  
Vol 190 (12) ◽  
pp. 6707-6707 ◽  
Author(s):  
Michael J. Osborn ◽  
Biao Ma ◽  
Suzanne Avis ◽  
Ashleigh Binnie ◽  
Jeanette Dilley ◽  
...  
Keyword(s):  

2000 ◽  
Vol 191 (7) ◽  
pp. 1253-1258 ◽  
Author(s):  
Michael R. Ehrenstein ◽  
H. Terence Cook ◽  
Michael S. Neuberger

Serum immunoglobulin (Ig)M provides the initial response to foreign antigen and plays a regulatory role in subsequent immune response development, accelerating the production of high-affinity IgG. Here we show that mice deficient in serum IgM have an increased propensity to spontaneous autoimmunity as judged by the development with age of serum IgG anti-DNA antibodies and the renal deposition of IgG and complement. They also exhibit augmented anti-DNA IgG production on exposure to lipopolysaccharide. Thus, deficiency in serum IgM leads to diminished responsiveness to foreign antigens but increased responsiveness to self—a paradoxical association reminiscent of that described in humans deficient in complement or IgA. We wondered whether serum IgM might play an analogous role with regard to the response to self-antigens. However, here—in contrast to the sluggish response to foreign antigens—we find that deficiency in serum IgM actually predisposes to the development of IgG antibodies to autoantigens.


Blood ◽  
1982 ◽  
Vol 59 (1) ◽  
pp. 61-68
Author(s):  
P Lalezari ◽  
JE Louie ◽  
N Fadlallah

Erythrocyte-bound immunoglobulins have been characterized by a PVP- potentiated antiglobulin test in 11 patients who had developed antibodies after treatment with alpha-methyldopa. Serologic profiles were recognized that could distinguish between the hemolyzing and nonhemolyzing patients: IgM antibodies together with the first component of complement (C1q) were demonstrated on erythrocytes of all eight hemolyzing patients. By contrast, these immunoproteins were absent from the cells of nonhemolyzing patients and became undetectable when the hemolyzing patients recovered. IgG and its subclasses were variably present on erythrocytes of all patients regardless of hemolytic activity. Eluates prepared from erythrocytes of the hemolyzing patients were shown to contain both IgG and IgM, and fixes C1q, C3, and C4. Eluates from the nonhemolyzing patients contained only IgG. The IgM antibodies differed from the commonly occurring cold agglutinins in that they were warm-reactive and were mainly concentrated on the patients' cells rather than being free in the serum. Because of their nonagglutinating property, it is suggested that they are monomeric IgM. It is concluded that the high affinity, warm- reactive IgM and not the IgG antibodies are primarily responsible for clinically manifest anemia in patients receiving alphamethyldopa and that the hemolytic activity is probably mediated by the classic pathway of complement activation.


2010 ◽  
Vol 391 (1) ◽  
pp. 750-755 ◽  
Author(s):  
Yukinari Kato ◽  
Chien-Tsun Kuan ◽  
Jinli Chang ◽  
Mika Kato Kaneko ◽  
Joanne Ayriss ◽  
...  

2013 ◽  
Vol 190 (4) ◽  
pp. 1481-1490 ◽  
Author(s):  
Michael J. Osborn ◽  
Biao Ma ◽  
Suzanne Avis ◽  
Ashleigh Binnie ◽  
Jeanette Dilley ◽  
...  
Keyword(s):  

Blood ◽  
1982 ◽  
Vol 59 (1) ◽  
pp. 61-68 ◽  
Author(s):  
P Lalezari ◽  
JE Louie ◽  
N Fadlallah

Abstract Erythrocyte-bound immunoglobulins have been characterized by a PVP- potentiated antiglobulin test in 11 patients who had developed antibodies after treatment with alpha-methyldopa. Serologic profiles were recognized that could distinguish between the hemolyzing and nonhemolyzing patients: IgM antibodies together with the first component of complement (C1q) were demonstrated on erythrocytes of all eight hemolyzing patients. By contrast, these immunoproteins were absent from the cells of nonhemolyzing patients and became undetectable when the hemolyzing patients recovered. IgG and its subclasses were variably present on erythrocytes of all patients regardless of hemolytic activity. Eluates prepared from erythrocytes of the hemolyzing patients were shown to contain both IgG and IgM, and fixes C1q, C3, and C4. Eluates from the nonhemolyzing patients contained only IgG. The IgM antibodies differed from the commonly occurring cold agglutinins in that they were warm-reactive and were mainly concentrated on the patients' cells rather than being free in the serum. Because of their nonagglutinating property, it is suggested that they are monomeric IgM. It is concluded that the high affinity, warm- reactive IgM and not the IgG antibodies are primarily responsible for clinically manifest anemia in patients receiving alphamethyldopa and that the hemolytic activity is probably mediated by the classic pathway of complement activation.


2004 ◽  
Vol 41 (10) ◽  
pp. 941-953 ◽  
Author(s):  
Charlotte G Jakobsen ◽  
Uffe Bodtger ◽  
Peter Kristensen ◽  
Lars K Poulsen ◽  
Erwin L Roggen

Blood ◽  
1983 ◽  
Vol 61 (6) ◽  
pp. 1258-1264 ◽  
Author(s):  
U Galili ◽  
A Korkesh ◽  
I Kahane ◽  
EA Rachmilewitz

A modified antiglobulin test, based on the high affinity between the Fc portion of the red blood cell (RBC) bound IgG and the Fc receptor on the myeloid cell K-562, was utilized for demonstration of immunoglobulins (Ig) on thalassemic RBC. Ig was found on the RBC of 73 out of 80 patients with thalassemia. The immunoglobulins on the thalassemic RBC belonged to the IgG subclass and were autoreactive. Elution studies utilizing various carbohydrates, or by thermal stripping, indicated that at least part of the IgG molecules found on the thalassemic RBC were specifically reactive with terminal galactosyl residues on the RBC membrane. IgG antibodies with similar reactivity were also demonstrated in normal human serum. These natural antigalactosyl IgG antibodies from normal sera could bind to IgG- depleted thalassemic RBC. Thalassemic RBC and normal senescent RBC were previously found to contain reduced amounts of membrane sialic acid (SA). It is suggested that the antigalactosyl IgG antibodies interact with newly exposed galactosyl residues underlying the sialic acid units. Such interaction may lead to the shortened lifespan of thalassemic RBC and may result in sequestration of senescent normal RBC by the reticuloendothelial system.


Sign in / Sign up

Export Citation Format

Share Document